TY - JOUR
T1 - Rectal cancer, version 2.2015
T2 - Featured updates to the NCCN guidelines
AU - Benson, Al B.
AU - Venook, Alan P.
AU - Bekaii-Saab, Tanios
AU - Chan, Emily
AU - Chen, Yi Jen
AU - Cooper, Harry S.
AU - Engstrom, Paul F.
AU - Enzinger, Peter C.
AU - Fenton, Moon J.
AU - Fuchs, Charles S.
AU - Grem, Jean L.
AU - Grothey, Axel
AU - Hochster, Howard S.
AU - Hunt, Steven
AU - Kamel, Ahmed
AU - Kirilcuk, Natalie
AU - Leong, Lucille A.
AU - Lin, Edward
AU - Messersmith, Wells A.
AU - Mulcahy, Mary F.
AU - Murphy, James D.
AU - Nurkin, Steven
AU - Rohren, Eric
AU - Ryan, David P.
AU - Saltz, Leonard
AU - Sharma, Sunil
AU - Shibata, David
AU - Skibber, John M.
AU - Sofocleous, Constantinos T.
AU - Stoffel, Elena M.
AU - Stotsky-Himelfarb, Eden
AU - Willett, Christopher G.
AU - Gregory, Kristina M.
AU - Freedman-Cass, Deborah
N1 - Publisher Copyright:
© National Comprehensive Cancer Network, Inc. 2015, All rights reserved.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - The NCCN Guidelines for Rectal Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Rectal Cancer Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize major discussion points from the 2015 NCCN Rectal Cancer Panel meeting. Major discussion topics this year were perioperative therapy options and surveillance for patients with stage I through III disease.
AB - The NCCN Guidelines for Rectal Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Rectal Cancer Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize major discussion points from the 2015 NCCN Rectal Cancer Panel meeting. Major discussion topics this year were perioperative therapy options and surveillance for patients with stage I through III disease.
UR - http://www.scopus.com/inward/record.url?scp=84932133656&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2015.0087
DO - 10.6004/jnccn.2015.0087
M3 - Article
C2 - 26085388
AN - SCOPUS:84932133656
SN - 1540-1405
VL - 13
SP - 719
EP - 728
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 6
ER -